For the second year in a row, Accell Clinical Research has had a privileged opportunity of exhibiting at the Annual Meeting of the American Society of Clinical Oncology (ASCO). Taking place in Chicago from June 2 to 6, 2017, ASCO drew more than 30,000 oncology professionals from around the world to discuss key advances and groundbreaking research in cancer. The theme of this year’s meeting was “Making a Difference in Cancer Care with You.” The size and scale of the conference were truly astounding.

The 2017 ASCO Annual Meeting unveiled top-line findings across the field of oncology. Pivotal research in immunotherapy, targeted agents, and supportive care were among the much-discussed abstracts this year.

It was a great pleasure and a fantastic experience for Accell’s team to exhibit at ASCO 2017. Company’s representatives from both departments of clinical operations and business development made an impressive statement enlightening attendees about noticeable advantages of conducting oncology clinical trials in Eastern European region including such aspects as fast patient recruitment, cost-effectiveness, and quality of data. This year’s conference was an effective catalyst to renew Accell’s acquaintances, forge new relationships and partnerships and discuss a common goal of accelerating cancer clinical trials and making more therapies available to more patients.

We cordially thank ASCO for a warm welcome and an opportunity to make new connections with the industry professionals, and we very much look forward to the next year’s conference.